Quarterly report pursuant to Section 13 or 15(d)

BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Details - Anti-Diluted EPS)

v3.22.2.2
BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Details - Anti-Diluted EPS) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2022
Mar. 31, 2022
Jun. 30, 2021
Mar. 31, 2021
Jun. 30, 2022
Jun. 30, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]            
Net Income / (Loss) $ 8,747 $ (517,828) $ (155,595) $ 82,739 $ (509,081) $ (72,856)
Less: cumulative dividends earned on Series A and Series B Preferred Stock (14,077)   (26,344)   (46,498) (47,032)
Net Income / (Loss) Attributable to common shareholders $ (5,330)   $ (181,939)   $ (555,579) $ (119,888)